The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.

All material subject to strictly enforced copyright laws. © 2022 Euromoney, a part of the Euromoney Institutional Investor PLC.

Sugita’s sickness

Katsuyuki Sugita

In early May, Katsuyuki Sugita, president of Dai-Ichi Kangyo Bank (DKB) and co-CEO of the newly created Mizuho Bank, returned to duty from sick leave. He made all the right noises to staff that he was fighting fit - "full of power and energy" - and ready to play a full part in the next stage of the merger of DKB, Fuji Bank and Industrial Bank of Japan (IBJ).

But insiders fear that Sugita's sickness will make the infighting for top jobs in Mizuho the more intense. A suspicious Mizuho spokesman asks how Euromoney has heard of Sugita's illness, before describing it as cystic duct narrowing. Rumours persist of an even more serious condition.

Until now, it was widely assumed that Sugita would become the head of the Mizuho holding company, leaving the president of IBJ, Masao Nishimura, to head the corporate bank and Yoshiro Yamamoto, president of Fuji Bank, to take charge of the commercial bank - a neat division of the spoils.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.


Unlimited access to and

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually


Unlimited access to and, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors


Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree